40 results
8-K
EX-99
GSTC
GlobeStar Therapeutics Corp
13 Nov 23
Other Events
12:32pm
, and shall be reimbursed all of its related costs and expenses
9. Certain Intellectual Property Rights Matters:
9.1. Responsibility Outside of Territory … , and copyright filings received or made by GTC outside of the Territory pertaining to GTC-IP.
9.2. Responsibility in Territory. IndiaCo shall recommend to GTC
8-K
EX-99
GSTC
GlobeStar Therapeutics Corp
22 Jun 23
Globestar Therapeutics Enters into Mou with Advanced Innovative Partners to Develop Clinical Studies for Multiple Sclerosis Treatment
5:18pm
will lead the effort, contribute related rights to Project Amethyst™, and have primary responsibility for financing, supply chain, manufacturing, and sales … of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information
8-K
EX-99
GSTC
GlobeStar Therapeutics Corp
12 Oct 21
Regulation FD Disclosure
8:27am
” or similar expressions. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information
8-K
EX-99
asjlh8i5q1rhejtn0d2
4 Oct 21
Regulation FD Disclosure
8:48am
8-K
EX-99
pdceqg26o
6 May 21
AngioSoma, Inc. Adds Brooke Greenwald As Chief Marketing Officer
5:27pm
8-K
EX-99
b7q1q2940d7w0w1hnyyd
6 May 21
AngioSoma, Inc. Adds Brooke Greenwald As Chief Marketing Officer
5:27pm
8-K
EX-99
41f6 j1c51
6 May 21
AngioSoma, Inc. Adds Brooke Greenwald As Chief Marketing Officer
5:27pm
8-K
EX-99
oe7 ese4suvy9fgtuulg
6 May 21
AngioSoma, Inc. Adds Brooke Greenwald As Chief Marketing Officer
5:27pm
8-K
EX-99
m89i0cdfm 9zv1s
16 Apr 21
AngioSoma, Inc. Is Pleased to Welcome William Farley to Its Board of Directors
4:20pm
8-K
EX-99
7rgygf5jncxg0
25 Feb 21
Angiosoma and its Subsidiary Somaceuticals Announce Amended and Restated Execution of Global License for Multiple Sclerosis Patent
5:30pm
8-K
EX-99
zpkjx9vk7wj72ax5o
9 Dec 20
SomaCeuticals Moving Forward With Treatment of Multiple Sclerosis
12:00am
8-K
EX-99
p81zmu
24 Aug 20
SomaCeuticals Acquires License for Treatment of Multiple Sclerosis
5:01pm
8-K
EX-99.1
rlvozrp8w
23 Oct 19
AngioSoma, Inc. Announces Settlement of Litigation
11:28am
8-K
EX-99
3us i9qtislp0
19 Aug 19
Regulation FD Disclosure
9:41pm